Finance

Beta
Lists
PROK:NASDAQ
ProKidney Corp
$1.89
+3.28%
(+0.060) 1D
$1.87
-1.06% (-0.020)
After hours
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PROK...
Open
$1.80
High
$1.95
Low
$1.80
Mkt. cap
570.89M
Avg. vol.
1.21M
Volume
1.44M
52-wk high
$7.13
52-wk low
$0.54
EPS
-$0.53
Beta
1.69
Shares outstanding
205.20M
No. of employees
231
Open
$1.80
High
$1.95
Low
$1.80
Mkt. cap
570.89M
Avg. vol.
1.21M
Volume
1.44M
52-wk high
$7.13
52-wk low
$0.54
EPS
-$0.53
Beta
1.69
Shares outstanding
205.20M
No. of employees
231
News stories
From sources across the web
About ProKidney Corp
CEO-
Employees231
Founded2015
HeadquartersWinston-Salem, North Carolina, United States
SectorBiotechnology
Websiteprokidney.com
Analyst ratings
Based on 4 analysts giving stock ratings to PROK in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PROK in the last 3 months.
Highest
Current $1.89
$12.00 (+534.92%)
Average
$5.75 (+204.23%)
Lowest
$1.00 (-47.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Guggenheim
Buy
Reiterated
$7.00
+270.4%
05/18/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$12.00
+534.9%
05/18/2026
Dina Ramadane
Bank of America Securities
Sell
Reiterated
$1.00
-47.1%
05/18/2026
Judah Frommer
Morgan Stanley
Hold
Reiterated
$3.00
+58.7%
05/18/2026
Anupam Rama
J.P. Morgan
Hold
Maintained
-
-
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
221.00K
217.00K
225.00K
226.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.88M
26.82M
34.16M
33.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.05M
11.62M
11.76M
11.32M
Operating expense
39.93M
38.44M
45.91M
45.16M
Total operating expenses
39.93M
38.44M
45.91M
45.16M
Operating income
-39.71M
-38.22M
-45.69M
-44.93M
Other non operating income
-
-
-
-
EBT including unusual items
-36.12M
-35.28M
-42.44M
-42.62M
EBT excluding unusual items
-36.12M
-34.96M
-42.76M
-42.62M
Income tax expense
848.00K
560.00K
-1.58M
-
Effective tax rate
-2.35%
-1.59%
3.73%
-
Other operating expenses
-
-
-
-
Net income
-16.55M
-16.47M
-19.23M
-20.04M
Net profit margin
-7,489.59%
-7,589.40%
-8,547.11%
-8,865.93%
Earnings per share
-0.13
-0.12
-0.14
-0.14
Interest and investment income
3.59M
3.26M
2.94M
2.33M
Interest expense
-1.00K
-2.00K
-1.00K
-15.00K
Net interest expenses
3.59M
3.26M
2.93M
2.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.24M
-36.55M
-43.85M
-43.28M
Gain or loss from assets sale
164.00K
10.00K
957.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer